NeuPath Health Inc.
NPTH.V
TSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -294.00K | 216.30K | -280.40K | -271.20K | 281.10K |
Total Depreciation and Amortization | 421.60K | 404.10K | 430.90K | 542.50K | 467.50K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 212.60K | 209.70K | 191.40K | 138.90K | -415.30K |
Change in Net Operating Assets | 310.90K | 57.70K | -276.70K | 154.40K | 700.00 |
Cash from Operations | 651.10K | 887.90K | 65.30K | 564.50K | 334.00K |
Capital Expenditure | -148.10K | -314.20K | -34.90K | -88.20K | -58.90K |
Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 1.45M |
Cash Acquisitions | 0.00 | 0.00 | -129.80K | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -148.10K | -314.20K | -164.70K | -88.20K | 1.39M |
Total Debt Issued | 25.00K | -- | -- | 0.00 | 0.00 |
Total Debt Repaid | -478.00K | -475.00K | -543.00K | -577.00K | -1.81M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 24.00K | 24.00K | 50.00K | 63.00K | 49.00K |
Cash from Financing | -314.50K | -329.60K | -365.70K | -377.80K | -1.31M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 188.40K | 244.10K | -465.10K | 98.50K | 414.50K |